Tonix Pharmaceuticals : Summary Investor Presentation April 2023
INVESTOR PRESENTATION NASDAQ: TNXP Version P0433 April 13, 2023 ©... | April 13, 2023
Tonix Pharmaceuticals Holding Corp Exchange Commission Cautionary Note Forward Looking Statements Private Securities Litigation Reform Act Annual Report
Source: marketscreener.com